top of page

Free eBook- CAPA in the Pharmaceutical and Biotech Industries

Writer's picture: Sharan MuruganSharan Murugan

Updated: May 27, 2022

According to the U.S. Food and Drug Administration (FDA), the purpose of a "CAPA program is to collect information, analyze information, identify and investigate product and quality problems, and take appropriate and effective corrective and/or preventive action to prevent their recurrence".

Corrective and Preventive Action procedures require analyzing processes, work operations, concessions, quality audit reports, quality records, service records, complaints, returned products, and other sources of quality data to identify existing and potential causes of a nonconforming product or other quality problems.


I found the below PDF available on LinkedIn while surfing and found it useful.


Thought it would be really helpful for all Quality Assurance and Regulatory Audit Professionals and specifically those who are accountable for taking major decisions.


Below PDF document that will help you to understand how to implement, develop, and maintain an effective corrective action and preventive action (CAPA) and investigation program using a nine-step closed-loop process approach for medical device, pharmaceutical, and biologic manufacturers.



Click the PDF below and understand CAPA by the nine-step process approach...






コメント


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page